Literature DB >> 16818753

Generation of T cell help through a MHC class I-restricted TCR.

Helmut W H G Kessels1, Koen Schepers, Marly D van den Boom, David J Topham, Ton N M Schumacher.   

Abstract

CD4+ T cells that are activated by a MHC class II/peptide encounter can induce maturation of APCs and promote cytotoxic CD8+ T cell responses. Unfortunately, the number of well-defined tumor-specific CD4+ T cell epitopes that can be exploited for adoptive immunotherapy is limited. To determine whether Th cell responses can be generated by redirecting CD4+ T cells to MHC class I ligands, we have introduced MHC class I-restricted TCRs into postthymic murine CD4+ T cells and examined CD4+ T cell activation and helper function in vitro and in vivo. These experiments indicate that Ag-specific CD4+ T cell help can be induced by the engagement of MHC class I-restricted TCRs in peripheral CD4+ T cells but that it is highly dependent on the coreceptor function of the CD8beta-chain. The ability to generate Th cell immunity by infusion of MHC class I-restricted Th cells may prove useful for the induction of tumor-specific T cell immunity in cases where MHC class II-associated epitopes are lacking.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16818753     DOI: 10.4049/jimmunol.177.2.976

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

Review 1.  New Strategies in Engineering T-cell Receptor Gene-Modified T cells to More Effectively Target Malignancies.

Authors:  Thomas M Schmitt; Ingunn M Stromnes; Aude G Chapuis; Philip D Greenberg
Journal:  Clin Cancer Res       Date:  2015-10-13       Impact factor: 12.531

2.  Dissecting T cell lineage relationships by cellular barcoding.

Authors:  Koen Schepers; Erwin Swart; Jeroen W J van Heijst; Carmen Gerlach; Maria Castrucci; Daoud Sie; Mike Heimerikx; Arno Velds; Ron M Kerkhoven; Ramon Arens; Ton N M Schumacher
Journal:  J Exp Med       Date:  2008-09-22       Impact factor: 14.307

3.  Antileukemia multifunctionality of CD4(+) T cells genetically engineered by HLA class I-restricted and WT1-specific T-cell receptor gene transfer.

Authors:  H Fujiwara; T Ochi; F Ochi; Y Miyazaki; H Asai; M Narita; S Okamoto; J Mineno; K Kuzushima; H Shiku; M Yasukawa
Journal:  Leukemia       Date:  2015-06-24       Impact factor: 11.528

4.  MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitro.

Authors:  Swagatam Ray; Arvind Chhabra; Nitya G Chakraborty; Upendra Hegde; David I Dorsky; Thinle Chodon; Erika von Euw; Begonya Comin-Anduix; Richard C Koya; Antoni Ribas; James S Economou; Steven A Rosenberg; Bijay Mukherji
Journal:  Clin Immunol       Date:  2010-05-23       Impact factor: 3.969

5.  Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy.

Authors:  Gavin M Bendle; Carsten Linnemann; Anna I Hooijkaas; Laura Bies; Moniek A de Witte; Annelies Jorritsma; Andrew D M Kaiser; Nadine Pouw; Reno Debets; Elisa Kieback; Wolfgang Uckert; Ji-Ying Song; John B A G Haanen; Ton N M Schumacher
Journal:  Nat Med       Date:  2010-04-18       Impact factor: 53.440

6.  Knockdown of T-bet expression in Mart-127-35 -specific T-cell-receptor-engineered human CD4(+)  CD25(-) and CD8(+) T cells attenuates effector function.

Authors:  Sidharth S Jha; Nitya G Chakraborty; Prashant Singh; Bijay Mukherji; David I Dorsky
Journal:  Immunology       Date:  2015-05       Impact factor: 7.397

7.  TCR gene therapy of spontaneous prostate carcinoma requires in vivo T cell activation.

Authors:  Moniek A de Witte; Gavin M Bendle; Marly D van den Boom; Miriam Coccoris; Todd D Schell; Satvir S Tevethia; Harm van Tinteren; Elly M Mesman; Ji-Ying Song; Ton N M Schumacher
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

8.  Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions.

Authors:  Paul F Robbins; Yong F Li; Mona El-Gamil; Yangbing Zhao; Jennifer A Wargo; Zhili Zheng; Hui Xu; Richard A Morgan; Steven A Feldman; Laura A Johnson; Alan D Bennett; Steven M Dunn; Tara M Mahon; Bent K Jakobsen; Steven A Rosenberg
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

9.  CD4+CD25- T cells transduced to express MHC class I-restricted epitope-specific TCR synthesize Th1 cytokines and exhibit MHC class I-restricted cytolytic effector function in a human melanoma model.

Authors:  Arvind Chhabra; Lili Yang; Pin Wang; Begoña Comin-Anduix; Raja Das; Nitya G Chakraborty; Swagatam Ray; Shikhar Mehrotra; Haiguang Yang; Cinnamon L Hardee; Roger Hollis; David I Dorsky; Richard Koya; Donald B Kohn; Antoni Ribas; James S Economou; David Baltimore; Bijay Mukherji
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

Review 10.  T-cell receptor gene therapy--ready to go viral?

Authors:  Terhi Karpanen; Johanna Olweus
Journal:  Mol Oncol       Date:  2015-10-20       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.